BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25800975)

  • 1. Targeted therapies for small cell lung cancer: Where do we stand?
    Arcaro A
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Therapy of Small Cell Lung Cancer.
    Schneider BJ; Kalemkerian GP
    Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
    Hensing T; Chawla A; Batra R; Salgia R
    Adv Exp Med Biol; 2014; 799():85-117. PubMed ID: 24292963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New targeted therapies and small-cell lung cancer.
    Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
    Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular targeted therapies in small-cell lung cancer].
    Levy A; Malouf GG; Besse B; Massard C; Soria JC
    Bull Cancer; 2010 May; 97(5):535-45. PubMed ID: 20093224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins, genetic landscape, and emerging therapies of small cell lung cancer.
    Semenova EA; Nagel R; Berns A
    Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?
    Fischer B; Marinov M; Arcaro A
    Cancer Treat Rev; 2007 Jun; 33(4):391-406. PubMed ID: 17368733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-cell lung cancer: an update on targeted therapies.
    Joshi M; Ayoola A; Belani CP
    Adv Exp Med Biol; 2013; 779():385-404. PubMed ID: 23288650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting hypoxia in the treatment of small cell lung cancer.
    Bryant JL; Meredith SL; Williams KJ; White A
    Lung Cancer; 2014 Nov; 86(2):126-32. PubMed ID: 25201720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
    Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
    Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganitumab for the treatment of small-cell lung cancer.
    Martínez P; Sales Fidalgo PA; Felip E
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1423-32. PubMed ID: 25189625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenging the recalcitrant disease-developing molecularly driven treatments for small cell lung cancer.
    Mak DWS; Li S; Minchom A
    Eur J Cancer; 2019 Sep; 119():132-150. PubMed ID: 31445197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in pharmacotherapy of small cell lung cancer.
    Kalemkerian GP
    Expert Opin Pharmacother; 2014 Nov; 15(16):2385-96. PubMed ID: 25255939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of small cell lung cancer: state of the art and new development.
    Sgambato A; Casaluce F; Maione P; Rossi A; Sacco PC; Panzone F; Ciardiello F; Gridelli C
    Expert Opin Pharmacother; 2013 Oct; 14(15):2019-31. PubMed ID: 23901936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the biology of SCLC: implications for therapy.
    Sabari JK; Lok BH; Laird JH; Poirier JT; Rudin CM
    Nat Rev Clin Oncol; 2017 Sep; 14(9):549-561. PubMed ID: 28534531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted agents in the management of small cell lung cancer - present and future.
    Srivastava R; Lebowicz Y; Jamil MO
    Drugs Today (Barc); 2018 Aug; 54(8):479-488. PubMed ID: 30209442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions.
    Allen J; Jahanzeb M
    Clin Lung Cancer; 2008 Sep; 9(5):262-70. PubMed ID: 18953759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of new targeted therapies in small-cell lung cancer.
    Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.